News

18.02.2020

Watch out for EpiCrossBorders – Our new international Research School

We are happy to present EpiCrossBorders, our new international research school for epigenetics across borders, aiming to establish new research topics and train future leaders in epigenetics. EpiCrossBorders will connect the research excellence of our epigenetics@HMGU community and the Edinburgh bioscience programs* hosted at the University of Edinburgh (Wellcome Centre for Cell Biology, MRC Human Genetics Unit and Centre for Regenerative Medicine).

EpiCrossBorders aims to prepare the new generation of scientist to tackle tomorrow's health challenges. Following the "One Health" approach of the World Health Organization, EpiCrossBorders will strengthen collaborations between different research areas to improve public health and tackle societal challenges at an international level.

Under the umbrella of HELENA, EpiCrossBorders will recruit and train early-career talents to study the impact of the environment and climate change on the epigenomes of living organisms using innovative, quantitative and multidisciplinary ways including Artificial Intelligence. Through the EpiCrossBorders program,  Edinburgh bioscience programs* and our Epigenetics@HMGU community with our Helmholtz Zentrum München research school EPIGRS on epigenetics launched in 2018  will team up and thus, the program involves an innovative mobility exchange concept between Munich and Edinburgh to foster the students’ curiosity and creativity.EpiCrossBorders will be funded by Helmholtz Zentrum München, the Initiative and Networking Fund of the Helmholtz Association and the partners from Edinburgh over a period of six years.  Applications for EpiCrossBorders are planned to open in the second half of 2020. 

Further information:

If you would like the full press release, go here.

For updates on EpiCrossBorders, please check out the homepage of EPIGRS and follow us on twitter.

*Integrative Cell Mechanisms (Wellcome Centre for Cell Biology); Human Genetics, Genomics and Disease and Biomedical Artificial Intelligence (MRC Human Genetics Unit); Regenerative Medicine (Centre for Regenerative Medicine)